Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Breast Neoplasms

Breast MRI and CEDM will be performed within 30 days of one another after neoadjuvant therapy

All women who are scheduled for a post-NAT breast MRI and mammogram will be asked to enroll in the study. The addition of contrast to the FFDM (CEDM) would be the only intervention.

Breast Magnetic Resonance Imaging (MRI)

Contrast Enhanced Mammography (CEDM)

Janice Sung, MD

The purpose of this study is to compare the diagnostic accuracy of breast magnetic resonance imaging (MRI) and contrast enhanced digital mammography (CEDM) in assessing the residual disease extent in patients who have completed neoadjuvant therapy (NAT).

Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery

Comparison of Breast Magnetic Resonance Imaging (MRI) and Contrast Enhanced Mammography (CEDM) to Evaluate Residual Disease Extent After Neoadjuvant Therapy (NAT)

To compare the diagnostic accuracy of enhancement on MRI and CEDM in evaluating residual disease extent in women who have completed NAT prior to surgical excision

Memorial Sloan Kettering Cancer Center

Breast Diseases

Skin Diseases

CEDM

Chen-Pin Chou, MD

To evaluate the effectiveness of Contrast-enhanced digital mammography (CEDM) in detecting breast cancer in women at higher risk.

The aim of this study was to evaluate the effectiveness of different imaging techniques for detecting breast cancer in women with a higher risk due to personal or family history of the disease.

CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study

The data that support the findings of this study are available on reasonable request from the corresponding author. Some data are not publicly available due to their containing information that could compromise the privacy of research participants.

This refers to the total number of individuals who underwent breast cancer screening or assessment and the number diagnosed with breast cancer. Evaluating the accuracy of screening tests using measures such as true positives and true negatives is crucial for assessing the reliability of screening tests and identifying potential issues. These measures help healthcare professionals make informed decisions about screening and diagnostic strategies.

This refers to the total number of individuals who underwent breast cancer screening or assessment and tested positive, requiring a biopsy and MRI for further evaluation. A biopsy is necessary to confirm whether an individual has breast cancer. Monitoring the diagnostic accuracy of breast cancer screening tests and the number of individuals requiring further procedures is essential for determining appropriate treatment or monitoring. Measures such as true positives and true negatives are used to evaluate the accuracy of screening tests.

The total number of true positive results obtained by the diagnostic method, indicating the cases with breast cancer that are correctly identified. A higher number of true positives demonstrates better performance in correctly identifying cases with breast cancer.

The total number of true negative results obtained by the diagnostic method, indicating the cases without breast cancer that are correctly identified. A higher number of true negatives demonstrates better performance in correctly identifying cases without breast cancer and reducing false positives.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery	NCT03070340	Breast Cancer	Breast Magnetic... Contrast Enhanc...	-	Memorial Sloan Kettering Cancer Center
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery	NCT03070340	Breast Cancer	Breast Magnetic... Contrast Enhanc...	-	Memorial Sloan Kettering Cancer Center
CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study	NCT05797129	Breast Cancer	CEDM	20 Years - 90 Years	Kaohsiung Veterans General Hospital.
CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study	NCT05797129	Breast Cancer	CEDM	20 Years - 90 Years	Kaohsiung Veterans General Hospital.

Spots Global Cancer Trial Database for cedm

Every month we try and update this database with for cedm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for cedm

Every month we try and update this database with for cedm cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for cedm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.